{"result": {"id": "chatcmpl-BBxrXmJ2Tc0EFVMCKDzKFDRPR7BzG", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CELLULAR QUIESCENCE<|>BIOLOGICAL PROCESS<|>Cellular quiescence is a state of dormancy in which cells are not actively dividing but can be activated under certain conditions.)\n##\n(\"entity\"<|>FRONT. CELL DEV. BIOL.<|>RESEARCH ARTICLE<|>A research article published in Frontiers in Cell and Developmental Biology in 2021 discussing cellular quiescence.)\n##\n(\"entity\"<|>K. FUJIMAKI<|>PERSON<|>K. Fujimaki is a researcher who has contributed to the study of cell dormancy plasticity and quiescence.)\n##\n(\"entity\"<|>G. YAO<|>PERSON<|>G. Yao is a researcher involved in the study of cellular dormancy and quiescence.)\n##\n(\"entity\"<|>CELL DORMANCY PLASTICITY<|>BIOLOGICAL PROCESS<|>Cell dormancy plasticity refers to the ability of cells to transition between quiescence and senescence.)\n##\n(\"entity\"<|>SENESCENCE<|>BIOLOGICAL PROCESS<|>Senescence is a state where cells cease to divide and can contribute to aging and tissue dysfunction.)\n##\n(\"entity\"<|>M.T. WEI<|>PERSON<|>M.T. Wei is a researcher who has modeled the depth of cellular dormancy using RNA-sequencing data.)\n##\n(\"entity\"<|>M.T. GORE<|>PERSON<|>M.T. Gore is a researcher who has studied endothelial cell flow-mediated quiescence.)\n##\n(\"entity\"<|>P27<|>FACTOR<|>p27 is a cell cycle inhibitor that plays a role in regulating quiescence in endothelial cells.)\n##\n(\"entity\"<|>NATURE<|>RESEARCH ARTICLE<|>A research article published in Nature discussing the role of mTORC1 in the transition of quiescent stem cells.)\n##\n(\"entity\"<|>HGFA<|>FACTOR<|>HGFA is an injury-regulated systemic factor that induces the transition of stem cells into GAlert.)\n##\n(\"entity\"<|>CELL STEM CELL<|>RESEARCH ARTICLE<|>A research article published in Cell Stem Cell discussing dormant neural stem cells that activate upon brain injury.)\n##\n(\"entity\"<|>JOURNAL OF CELL BIOLOGY<|>RESEARCH ARTICLE<|>A research article published in the Journal of Cell Biology discussing cellular senescence.)\n##\n(\"entity\"<|>GENOMIC HALLMARKS<|>GENE<|>Genomic hallmarks refer to specific genetic features associated with cellular states, such as G0 cell cycle arrest in cancer.)\n##\n(\"relationship\"<|>CELLULAR QUIESCENCE<|>CELL DORMANCY PLASTICITY<|>Cellular quiescence is a state that can transition into senescence, illustrating the concept of dormancy plasticity.<|>8)\n##\n(\"relationship\"<|>K. FUJIMAKI<|>FRONT. CELL DEV. BIOL.<|>K. Fujimaki authored a research article discussing cellular dormancy plasticity in Frontiers in Cell and Developmental Biology.<|>7)\n##\n(\"relationship\"<|>G. YAO<|>FRONT. CELL DEV. BIOL.<|>G. Yao co-authored a research article discussing cellular dormancy plasticity in Frontiers in Cell and Developmental Biology.<|>7)\n##\n(\"relationship\"<|>M.T. WEI<|>GENOMIC HALLMARKS<|>M.T. Wei's research involves modeling cellular dormancy, which relates to genomic hallmarks of cell cycle arrest.<|>6)\n##\n(\"relationship\"<|>M.T. GORE<|>P27<|>M.T. Gore's research on endothelial cell quiescence involves the regulation by the cell cycle inhibitor p27.<|>7)\n##\n(\"relationship\"<|>HGFA<|>CELL STEM CELL<|>HGFA induces the transition of stem cells into GAlert, which is relevant to the study of cellular quiescence and activation.<|>8)\n##\n(\"relationship\"<|>NATURE<|>M.T. WEI<|>M.T. Wei's research on cellular dormancy is relevant to the findings discussed in Nature regarding mTORC1 and quiescent stem cells.<|>7)\n##\n(\"relationship\"<|>JOURNAL OF CELL BIOLOGY<|>CELLULAR SENESCENCE<|>The Journal of Cell Biology published research discussing the mechanisms and implications of cellular senescence.<|>6)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1742191419, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_3267753c5d", "usage": {"completion_tokens": 977, "prompt_tokens": 4183, "total_tokens": 5160, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 2944}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n\n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [research article, person, cell type, biological process, gene, institution, factor]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n\n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: an integer score between 1 to 10, indicating strength of the relationship between the source entity and target entity\nFormat each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n\n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n\n4. If you have to translate into English, just translate the descriptions, nothing else!\n\n5. When finished, output <|COMPLETE|>.\n\n-Examples-\n######################\n\nExample 1:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n Become Activated upon Brain Injury.Cell Stem Cell2015,17, 329–340. [CrossRef]\n44.Rodgers, J.T.; Schroeder, M.D.; Ma, C.; Rando, T.A. HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of\nStem Cells into GAlert.Cell Rep.2017,19, 479–486. [CrossRef]\n45.Lee, G.; Espirito Santo, A.I.; Zwingenberger, S.; Cai, L.; Vogl, T.; Feldmann, M.; Horwood, N.J.; Chan, J.K.; Nanchahal, J. Fully\nreduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.Proc. Natl. Acad. Sci. USA\n2018,115, E4463–E4472.\n46. Baker, D.J.; Sedivy, J.M. Probing the depths of cellular senescence. J. Cell Biol.2013,202, 11–13. [CrossRef]\n47. Van Deursen, J.M. The role of senescent cells in ageing. Nature2014,509,\n------------------------\noutput:\n(\"entity\"<|>CELL STEM CELL<|>RESEARCH ARTICLE<|>A research article published in Cell Stem Cell in 2015 discussing activation upon brain injury)\n##\n(\"entity\"<|>HGFA<|>FACTOR<|>HGFA is an injury-regulated systemic factor that induces the transition of stem cells into GAlert)\n##\n(\"entity\"<|>GAlert<|>CELL TYPE<|>GAlert is a state of stem cells that is induced by HGFA during injury)\n##\n(\"entity\"<|>CELL REPORT<|>RESEARCH ARTICLE<|>A research article published in Cell Reports in 2017 discussing the role of HGFA in stem cell transition)\n##\n(\"entity\"<|>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA<|>RESEARCH ARTICLE<|>A research article published in PNAS in 2018 discussing the effects of fully reduced HMGB1 on tissue regeneration)\n##\n(\"entity\"<|>HMGB1<|>FACTOR<|>HMGB1 is a factor that accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert)\n##\n(\"entity\"<|>JOURNAL OF CELL BIOLOGY<|>RESEARCH ARTICLE<|>A research article published in the Journal of Cell Biology in 2013 discussing cellular senescence)\n##\n(\"entity\"<|>NATURE<|>RESEARCH ARTICLE<|>A research article published in Nature in 2014 discussing the role of senescent cells in aging)\n##\n(\"entity\"<|>D.J. BAKER<|>PERSON<|>D.J. Baker is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. SEDIVY<|>PERSON<|>J.M. Sedivy is a researcher who has probed the depths of cellular senescence)\n##\n(\"entity\"<|>J.M. VAN DEURSEN<|>PERSON<|>J.M. Van Deursen is a researcher discussing the role of senescent cells in aging)\n##\n(\"relationship\"<|>HGFA<|>GAlert<|>HGFA induces the transition of stem cells into GAlert<|>8)\n##\n(\"relationship\"<|>HMGB1<|>GAlert<|>Fully reduced HMGB1 accelerates the regeneration of tissues by transitioning stem cells to GAlert<|>8)\n##\n(\"relationship\"<|>D.J. BAKER<|>JOURNAL OF CELL BIOLOGY<|>D.J. Baker authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. SEDIVY<|>JOURNAL OF CELL BIOLOGY<|>J.M. Sedivy authored a research article discussing cellular senescence in the Journal of Cell Biology<|>7)\n##\n(\"relationship\"<|>J.M. VAN DEURSEN<|>NATURE<|>J.M. Van Deursen authored a research article discussing the role of senescent cells in aging in Nature<|>7)\n<|COMPLETE|>\n#############################\n\n\nExample 2:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\nshort exposure (6 h) to either drug was sufficient to inhibit ly-\n\nsosomal function in REF cells, evident by the impaired pro-\n\nteolytic degradation within the lysosomal compartment (\n\nSI\n\nAppendix\n\n, Fig. S5\nA\n). When quiescent cells were treated with\n\neither of these 2 lysosomal inhibitors, increasingly higher serum\nconcentrations were required to activate cells to reenter the cell\n\ncycle, in a drug dose-dependent manner (Fig. 4\n\nB\n–\nD\n; red arrow\n\npoints to serum concentration for activating\n\n∼\n50% of cells, judged\n\nbased on EdU incorporation, E2f-GFP reporter, and propidium\n\niodide [PI] staining, respectively). Correspondingly, at a given\nserum concentration (e.g., 4% serum), a decreasing percentage of\n\ncells were able to reenter the cell cycle (EdU\n+\n)withanincreasing\n\ndose of either lysosomal inhibitor, Baf or CQ (Fig. 4\n\nB\n). The ly-\n\nsosomal inhibition-caused quiescence deepening occurred re-\n\ngardless of the preceding quiescence depth before drug treatment:\n\nAs shown in\n\n\n------------------------\noutput:\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research that exhibit lysosomal function and are affected by drug treatments.)\n##\n(\"entity\"<|>LYSOSOMAL INHIBITORS<|>FACTOR<|>Lysosomal inhibitors are substances that impair lysosomal function, affecting cellular processes such as proteolytic degradation.)\n##\n(\"entity\"<|>BAF<|>FACTOR<|>Baf is a specific lysosomal inhibitor that affects the reentry of quiescent cells into the cell cycle.)\n##\n(\"entity\"<|>CQ<|>FACTOR<|>CQ is another lysosomal inhibitor that impacts the ability of quiescent cells to reactivate and reenter the cell cycle.)\n##\n(\"entity\"<|>EDU INCORPORATION<|>BIOLOGICAL PROCESS<|>EdU incorporation is a method used to measure cell proliferation by detecting newly synthesized DNA in cells.)\n##\n(\"entity\"<|>E2F-GFP REPORTER<|>BIOLOGICAL PROCESS<|>E2F-GFP reporter is a tool used to monitor cell cycle progression and activation in response to serum concentrations.)\n##\n(\"entity\"<|>PROPIDIUM IODIDE STAINING<|>BIOLOGICAL PROCESS<|>Propidium iodide staining is a technique used to assess cell viability and cell cycle status by staining DNA.)\n##\n(\"relationship\"<|>REF CELLS<|>LYSOSOMAL INHIBITORS<|>Lysosomal inhibitors impair the lysosomal function in REF cells, affecting their ability to degrade proteins and reenter the cell cycle.<|>8)\n##\n(\"relationship\"<|>REF CELLS<|>BAF<|>Baf treatment leads to a dose-dependent inhibition of REF cells' ability to reenter the cell cycle.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>CQ<|>CQ treatment also inhibits REF cells' ability to reactivate and reenter the cell cycle in a dose-dependent manner.<|>7)\n##\n(\"relationship\"<|>REF CELLS<|>EDU INCORPORATION<|>EdU incorporation is used to assess the percentage of REF cells that can reenter the cell cycle after treatment with lysosomal inhibitors.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>E2F-GFP REPORTER<|>The E2F-GFP reporter is utilized to monitor the activation of REF cells in response to serum concentrations.<|>6)\n##\n(\"relationship\"<|>REF CELLS<|>PROPIDIUM IODIDE STAINING<|>Propidium iodide staining is employed to evaluate the cell cycle status of REF cells after treatment with lysosomal inhibitors.<|>6)\n<|COMPLETE|>\n#############################\n\n\nExample 3:\n\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext:\n lysosomal function continuously modulates quiescence\ndepth, acting like a dimmer switch (Fig. 6\n\nH\n).\n\nQuiescence Deepening Is Linked to Cellular Senescence and Aging.\n\nFinally, we examined whether and how deep quiescence in REF\n\ncells is related to the quiescent states of other cell types (case Q)\nand other nongrowth cellular states, such as senescence (case S).\n\nTo this end, we first developed a gene-expression signature in-\n\ndicating the quiescence depth in REF cells by performing a\nlinear regression analysis of the time-course RNA-seq data (see\n\nMaterials and Methods\n\nfor details). To identify a signature that\n\ncorresponds to a deepening of quiescence as opposed to simply\n\nhalting the cell cycle, we omitted the proliferating sample (0 d) from\nthe analysis and used samples corresponding to 2- to 16-d\nserum\n\nstarvation (i.e., shallow to deep quiescence) to build the regression\n\nmodel. We next applied this quiescence-depth signature to other\npublicly available RNA-seq datase\nts related to cases Q and S, above.\n\nAB CD\n\nE\n\nGH\n\nF\n\n\n\n------------------------\noutput:\n(\"entity\"<|>LYSOSOMAL FUNCTION<|>BIOLOGICAL PROCESS<|>Lysosomal function is involved in modulating cellular quiescence and is linked to cellular senescence and aging.)\n##\n(\"entity\"<|>QUIESCENCE<|>BIOLOGICAL PROCESS<|>Quiescence refers to a state of cellular dormancy where cells are not actively dividing but can be activated under certain conditions.)\n##\n(\"entity\"<|>CELLULAR SENESCENCE<|>BIOLOGICAL PROCESS<|>Cellular senescence is a state where cells cease to divide and can contribute to aging and tissue dysfunction.)\n##\n(\"entity\"<|>AGING<|>BIOLOGICAL PROCESS<|>Aging is the process of becoming older, characterized by a gradual decline in physiological function and increased susceptibility to diseases.)\n##\n(\"entity\"<|>REF CELLS<|>CELL TYPE<|>REF cells are a type of cell used in research to study quiescence and cellular responses to various stimuli.)\n##\n(\"entity\"<|>GENE-EXPRESSION SIGNATURE<|>GENE<|>A gene-expression signature is a specific pattern of gene expression that can indicate particular cellular states, such as quiescence depth.)\n##\n(\"relationship\"<|>LYSOSOMAL FUNCTION<|>QUIESCENCE<|>Lysosomal function modulates quiescence, affecting how cells enter and maintain this dormant state<|>8)\n##\n(\"relationship\"<|>QUIESCENCE<|>CELLULAR SENESCENCE<|>Quiescence is linked to cellular senescence, as both processes involve changes in cell cycle activity and can influence aging<|>7)\n##\n(\"relationship\"<|>CELLULAR SENESCENCE<|>AGING<|>Cellular senescence contributes to the aging process by promoting tissue dysfunction and limiting regenerative capacity<|>9)\n##\n(\"relationship\"<|>REF CELLS<|>QUIESCENCE<|>REF cells are used to study the mechanisms of quiescence and how it can be influenced by various factors<|>6)\n##\n(\"relationship\"<|>GENE-EXPRESSION SIGNATURE<|>QUIESCENCE<|>The gene-expression signature developed indicates the depth of quiescence in REF cells, providing insights into their cellular state<|>8)\n<|COMPLETE|>\n#############################\n\n\n\n-Real Data-\n######################\nentity_types: [research article, person, cell type, biological process, gene, institution, factor]\ntext: Cellular Quiescence?Front. Cell Dev. Biol.\n2021,9, 739780. [CrossRef]\n41.Fujimaki, K.; Yao, G. Cell dormancy plasticity: Quiescence deepens into senescence through a dimmer switch.Physiol. Genom.\n2020,52, 558–562. [CrossRef]\n42.Rodgers, J.T.; King, K.Y.; Brett, J.O.; Cromie, M.J.; Charville, G.W.; Maguire, K.K.; Brunson, C.; Mastey, N.; Liu, L.;Tsai, C.-R.; et al.\nmTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert).Nature2014,510, 393–396. [CrossRef]\n[PubMed]\n43.Llorens-Bobadilla, E.; Zhao, S.; Baser, A.; Saiz-Castro, G.; Zwadlo, K.; Martin-Villalba, A. Single-Cell Transcriptomics Reveals a\nPopulation of Dormant Neural Stem Cells that Become Activated upon Brain Injury.Cell Stem Cell2015,17, 329–340. [CrossRef]\n44.Rodgers, J.T.; Schroeder, M.D.; Ma, C.; Rando, T.A. HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of\nStem Cells into GAlert.Cell Rep.2017,19, 479–486. [CrossRef]\n45.Lee, G.; Espirito Santo, A.I.; Zwingenberger, S.; Cai, L.; Vogl, T.; Feldmann, M.; Horwood, N.J.; Chan, J.K.; Nanchahal, J. Fully\nreduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert.Proc. Natl. Acad. Sci. USA\n2018,115, E4463–E4472.\n46. Baker, D.J.; Sedivy, J.M. Probing the depths of cellular senescence. J. Cell Biol.2013,202, 11–13. [CrossRef]\n47. Van Deursen, J.M. The role of senescent cells in ageing. Nature2014,509, 439–446. [CrossRef]\n48.Zhang, X.; Liu, X.; Du, Z.; Wei, L.; Fang, H.; Dong, Q.; Niu, J.; Li, Y.; Gao, J.; Zhang, M.Q.; et al. The loss of heterochromatin\nis associated with multiscale three-dimensional genome reorganization and aberrant transcription during cellular senescence.\nGenome Res.2021,31, 1121–1135. [CrossRef]\n49.Hernandez-Segura, A.; de Jong, T.V.; Melov, S.; Guryev, V.; Campisi, J.; DeMaria, M. Unmasking Transcriptional Heterogeneity in\nSenescent Cells.Curr. Biol.2017,27, 2652–2660.e4. [CrossRef] [PubMed]\n50.Wei, M.Y.; Yao, G. Modeling the Depth of Cellular Dormancy from RNA-Sequencing Data.Methods Mol. Biol.2024,2811, 123–135.\n[PubMed]\n51.Urban, N.; Cheung, T.H. Stem cell quiescence: The challenging path to activation.Development2021,148, dev165084. [CrossRef]\n[PubMed]\n52.Brooks, R.F. Cell Cycle Commitment and the Origins of Cell Cycle Variability.Front. Cell Dev. Biol.2021,9, 698066. [CrossRef]\n[PubMed]Biomedicines2024,12, 1837\n 8 of 8\n\n53.Truskowski, K.; Amend, S.R.; Pienta, K.J. Dormant cancer cells: Programmed quiescence, senescence, or both?Cancer Metastasis\nRev.2023,42, 37–47. [CrossRef] [PubMed]\n54.Wiecek, A.J.; Cutty, S.J.; Kornai, D.; Parreno-Centeno, M.; Gourmet, L.E.; Tagliazucchi, G.M.; Jacobson, D.H.; Zhang, P.; Xiong, L.;\nBond, G.L.; et al. Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer.Genome Biol.2023,24, 128.\n[CrossRef]\n55.Tanke, N.T.; Liu, Z.; Gore, M.T.; Bougaran, P.; Linares, M.B.; Marvin, A.; Sharma, A.; Oatley, M.; Yu, T.; Quigley, K.; et al.\nEndothelial Cell Flow-Mediated Quiescence Is Temporally Regulated and Utilizes the Cell Cycle Inhibitor p27.Arter. Thromb.\nVasc. Biol.2024,44, 1265–1282. [CrossRef] [PubMed]\n56.Ashraf, H.M.; Fernandez, B.; Spencer, S.L. The intensities of canonical senescence biomarkers integrate the duration of cell-cycle\nwithdrawal.Nat. Commun.2023,14, 4527. [CrossRef] [PubMed]\n57. de Magalhaes, J.P. Cellular senescence in normal physiology. Science2024,384, 1300–1301. [CrossRef] [PubMed]\n58.Leeman, D\n######################\noutput:", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}